EOLS Earnings

EOLS reported its FY2025Q3 earnings on 2025-11-05, showcasing a revenue of 69.00M against an estimate of 67.00M, resulting in a 2.29% surprise. The EPS was -0.14, surpassing the expected -0.19 by 26.32% . The stock experienced a 5.43% price change on the earnings day and a 2.64% change over the next five days, reflecting market reactions to the results.

Following EOLS's FY2025Q3 earnings announcement on 2025-11-05, the stock price moved by 5.43% on the day of the release. Over the subsequent five days, it saw a 2.64% change. Historically, EOLS's stock price tends to shift by an average of -5.14% in the 10 days leading up to earnings and -3.98% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate EOLS’s annual revenue to reach 91.00M, while the EPS is projected at 0.00. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Upward by 0.57% and EPS estimates Revise Upward by 0.49% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between EOLS's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were Revise Upward by 0.57%, while EPS estimates moved Revise Upward by 0.49% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, EOLS's stock price typically moves by -5.14% in the 10 days before its earnings and -3.98% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of 0.00 and revenue of 91.00M.

The earnings call and Q&A reflect a positive outlook, with strong product adoption, strategic cost optimization, and promising guidance for Q4. Despite some headwinds, the company anticipates a strong Q4, supported by effective marketing strategies and expected seasonal demand. The positive sentiment is further bolstered by the focus on expanding training for Evolysse, strategic bundling with Jeuveau, and the potential for long-term revenue growth. However, the lack of specific guidance on tariffs and sales splits introduces some uncertainty, warranting a cautious but optimistic rating.